Filing Details

Accession Number:
0001214659-17-005694
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-20 19:14:18
Reporting Period:
2017-09-20
Accepted Time:
2017-09-20 19:14:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509643 Craig John Thompson 25801 Industrial Blvd Suite B
Hayward CA 94545
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-20 8,550 $1.32 19,848 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person acquired the shares in the open market at a cost of $1.32 per share.